Tataramide B

Catalog No. :
ACRLTH600
CAS No. :
187655-56-7
Molecular Formula :
C36H36N2O8
Molecular Weight :
624.69

IUPAC Name:(2S,3S)-2-(4-hydroxy-3-methoxyphenyl)-N-(4-hydroxyphenethyl)-5-((Z)-3-((4-hydroxyphenethyl)amino)-3-oxoprop-1-en-1-yl)-7-methoxy-2,3-dihydrobenzofuran-3-carboxamide

Tataramide B structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameTataramide B
IUPAC Name(2S,3S)-2-(4-hydroxy-3-methoxyphenyl)-N-(4-hydroxyphenethyl)-5-((Z)-3-((4-hydroxyphenethyl)amino)-3-oxoprop-1-en-1-yl)-7-methoxy-2,3-dihydrobenzofuran-3-carboxamide
MDL No.MFCD29049481
Molecular FormulaC36H36N2O8
Molecular Weight624.69
SMILESCOC1=C(O)C=CC([C@H]2OC3=C(C=C(/C=C\C(=O)NCCC4=CC=C(O)C=C4)C=C3OC)[C@@H]2C(=O)NCCC2=CC=C(O)C=C2)=C1
InChI KeyDROXVBRNXCRUHP-ZKKKORKESA-N
SynonymTataramide B;(2R,3R)-rel-2,3-Dihydro-2-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]-5-[(1Z)-3-[[2-(4-hydroxyphenyl)ethyl]amino]-3-oxo-1-propen-1-yl]-7-methoxy-3-benzofurancarboxamide;3-Benzofurancarboxamide, 2,3-dihydro-2-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]-5-[(1Z)-3-[[2-(4-hydroxyphenyl)ethyl]amino]-3-oxo-1-propen-1-yl]-7-methoxy-, (2R,3R)-rel-
CAS No.187655-56-7

Synthetic Route by SureRoute

1. ACRLTH600 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRLTH600 route product structure diagram
    ACRLTH600187655-56-7
Inquiry

2. ACRLTH600 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRLTH600 route product structure diagram
    ACRLTH600187655-56-7
Inquiry

Comments (0)